Natural Anti-Inflammatory Capsule for Ulcerative Colitis Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current medications for ulcerative colitis are often ineffective, expensive, and contain synthetic or inert compounds, lacking a long-term positive impact on the body, with a need for an organic, over-the-counter alternative.

Innovation Solution

A medication comprising ginger root, blueberry extract, turmeric extract, anticaking agents, and fillers in a capsule form, providing a natural and inexpensive treatment option that reduces inflammation and eliminates the risk of complications such as colon cancer without the need for surgery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current medications (synthetics or combinations with inert compounds) are used to treat ulcerative colitis, then symptoms may be temporarily suppressed, but they are not always effective, lack long-term positive effect, and are expensive

Engineering Contradiction:
ImproveeffectivenessVSAvoidcost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent replaces expensive synthetic medications with a cost-effective natural alternative using common organic ingredients (ginger root, blueberry extract, turmeric extract) that can be obtained over-the-counter, significantly reducing treatment cost while maintaining therapeutic effectiveness

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the chemical composition parameters from synthetic compounds to natural organic compounds, specifically using gingerol from ginger root, anthocyanins from blueberry extract, and curcumin from turmeric extract, which fundamentally alters the treatment approach from conventional synthetic drugs to natural anti-inflammatory agents

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If current medications are used to treat ulcerative colitis, then some symptom relief may be achieved, but they often contain synthetic or inert compounds and are not always effective

Engineering Contradiction:
Improveinflammation reductionVSAvoidlong-term positive effect
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent converts potentially harmful synthetic compounds into beneficial natural compounds by using ginger root, blueberry extract, and turmeric extract - substances with established safety profiles and anti-inflammatory properties that provide long-term health benefits rather than temporary suppression

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent creates a composite natural medication combining three different plant extracts (ginger, blueberry, turmeric) that work synergistically to reduce inflammation through multiple mechanisms, providing more reliable and comprehensive treatment than single-ingredient synthetic medications

Inventive Principle:
Principle #40Composite materials

3Reliability

If surgery (removal of the colon) is performed to cure ulcerative colitis, then the disease can be cured, but it is a severe intervention with significant impact on the patient's body

Engineering Contradiction:
Improvecure rateVSAvoidsurgical complications
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-inflammatory action using natural compounds that prevent disease progression and complications (such as colon cancer) before they occur, allowing patients to avoid surgery by managing the condition medically with gingerol, anthocyanins, and curcumin

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses natural plant extracts as intermediary substances that mediate between the diseased state and complete remission, providing a middle-ground treatment option that avoids both the limitations of synthetic medications and the severity of surgical intervention

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS11219661B2Ulcerative colitis medication
Publication Date: 2022.01.11 CAMPBELL PAUL
  • US11219661B2 patent drawing
  • US11219661B2 patent drawing

AI summary

An illustrated side view of an exemplary medication for treating ulcerative colitis is presented. The medication is useful for reducing the risk and debilitation associated with having ulcerative colitis, as well as improving overall health. The medication further is useful for removing life threatening complications such as, but not limited to, perforated colon, liver disease, inflammation of skin, joints and eyes, decreasing the risk of colon cancer while eliminating the need for surgery for relief of the ulcerative colitis. The medication is also inexpensive and all natural.